Adolescent obesity has become a serious public health issue. Adolescents are at a unique stage of physiological and psychological development, where lifestyle interventions and pharmacological treatments show limited effectiveness for some severely obese cases. While bariatric surgery yields significant results, it carries risks such as high invasiveness and potential complications. Endoscopic bariatric therapies offer a minimally invasive, reversible, and effective new option for treating ado-lescent obesity, bridging the gap between lifestyle interventions and surgical procedures. In the future, the field of endoscopic bariatric treatment for adolescents will advance toward greater precision, systematization, and humanization. Through multidis-ciplinary collaboration, a comprehensive management system will be established, while psychological support and family in-volvement will enhance overall health outcomes.
Key words
adolescent /
obesity /
endoscope /
bariatric treatment
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
［1］ Apovian CM. Obesity: definition, comorbidities, causes, and burden［J］. Am J Manag Care，2016，22(suppl7):176-185. PMID: 27356115.
［2］ O'Connor EA, Evans CV, Burda BU, et al. Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force［J］. JAMA, 2017, 317(23): 2427-2444. DOI：10.1001/jama.2017.0332.
［3］ Torbahn G, Lischka J, Brown T, et al. Anti-obesity medication in the management of children and adolescents with obesity: Recent developments and research gaps［J］. Clin Endocrinol (Oxf)，2025，102(1): 51-61. DOI：10.1111/cen.15133.
［4］ Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP［J］. Surg Endosc，2020，34: 2332-2358. DOI：10.1007/s00464-020-07555-y.
［5］ Salminen P, Kow L, Aminian A, Kaplan LM, et al. IFSO consensus on definitions and clinical practice guidelines for obesity management：an international delphi study［J］. Obes Surg，2024，34(1): 30-42. DOI：10.1007/s11695-023-06913-8.
［6］ Calcaterra V, Cena H, Pelizzo G, et al. Bariatric surgery in adolescents: to do or not to do?［J］. Children (Basel)，2021，8（6）：453. DOI：10.3390/children8060453.
［7］ Alqahtani AR, Elahmedi M, Abdurabu HY, et al. Ten-year outcomes of children and adolescents who underwent sleeve gastrectomy: weight loss, comorbidity resolution, adverse events, and growth velocity［J］. J Am Coll Surg，2021，233(6): 657-664. DOI：10.1016/j.jamcollsurg.2021.08.678.
［8］ Shehata M, Abosena W, Elhaddad A, et al. Seven years follow-up after sleeve gastrectomy in adolescents［J］. Obes Surg，2025，35(7): 2680-2688. DOI：10.1007/s11695-025-07966-7.
［9］ Abu Dayyeh B, Kumar N, Edmundowicz SA, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies［J］. Gastrointest Endosc，2015，82: 425-438. DOI：10.1016/j.gie.2015.03.1964.
［10］ Moura D, Oliveira J, De Moura EGH, et al. Effectiveness of intragastric balloon for obesity: A systematic review and meta- analysis based on randomized control trial［J］. Surg Obes Relat Dis，2016，12: 420-429. DOI：10.1016/j.soard.2015.10.077.
［11］ Ohta M, Maekawa S, Imazu H, et al. Endoscopic intragastric balloon therapy for 15 years in Japan: Results of nationwide surveys［J］. Asian J Endosc Surg，2021，14(3): 401-407. DOI：10.1111/ases.12881.
［12］ Fittipaldi-Fernandez RJ, Guedes MR, Galvao Neto MP, et al. Efficacy of intragastric balloon treatment for adolescent obesity［J］. Obes Surg，2017，27(10):2546-2551. DOI：10.1007/s11695-017-2699-1.
［13］ Oyola C, Berry M, Salazar MAP, et al. Successful weight loss in adolescents with overweight or obesity using a swallowable intragastric balloon and nutritional oversight［J］. Obes Surg，2024，34(10): 3762-3770. DOI：10.1007/s11695-024-07458-0.
［14］ Abu Dayyeh, Barham KAcosta, Andres J，et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective，multicentre，randomised trial［J］. Lancet，2022，400(10350): 441-451. DOI：10.1016/S0140-6736(22)01280-6.
［15］ Vargas EJ, Rizk M, Gomez-Villa J, et al. Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: A comparative prospective study［J］. Gut，2023，72(6):1073-1080. DOI：10.1136/gutjnl-2022-327816.
［16］ Alqahtani A, Elahmedi M, Alqahtani YA, et al. Endoscopic sleeve gastroplasty in 109 consecutive children and adolescents with obesity: Two-year outcomes of a new modality［J］. Am J Gastroenterol，2019，114(12): 1857-1862. DOI：10.14309/ajg.0000000000000440.
［17］ Chen W, Feng J, Dong S, et al. Efficacy and safety of duodenal-jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta-analysis［J］. Obes Rev，2024，25(11): e13812. DOI：10.1111/obr.13812.
［18］ 周艳华, 张倩, 张澍田, 等. 内镜下胃转流支架系统治疗肥胖的疗效和安全性分析［J］. 中华消化内镜杂志, 2024, 41(1)：18-24. DOI: 10.3760/cma.j.cn321463-20230912-00377.
［19］ 王存川，周福庆，董志勇. 国际减重与代谢外科最新动态和评价［J］. 中国实用外科杂志, 2023, 43(5):503-509. DOI：10.19538/j.cjps.issn1005-2208.2023.05.05.
